The stone-cold, postrecession mergers-and-acquisitions market has gradually heated into a 2014 deals market that could be the best year since 2007.
"It's a seller's market," said Leslie Frecon, founder and CEO of LFE Capital, which sold one of its portfolio companies in the second quarter ended June 30.
Medtronic's controversial bid to buy Ireland-based Covidien for $46.2 billion, and switch headquarters from Minnesota to Ireland for the lower tax rate, has generated national headlines along with several other "tax-inversion" megadeals among multinational companies.
The pending Medtronic-Covidien deal is the largest ever involving a Minnesota company. But that one transaction has overshadowed the growing number of Minnesota-connected deals and rising purchase prices that indicate buyers and sellers have growing confidence in the accelerating U.S. economy.
"Companies are proactively looking for opportunities to grow, expand their footprint and adapt to changing industry and macroeconomic trends to position themselves for the future," said Martyn Curragh, PricewaterhouseCoopers' U.S. deals leader, said in a July report.
In the first half of 2014, there were 203 transactions involving a Minnesota-based company as a buyer or seller compared with 145 in the year-ago period — up 40 percent.
One of the largest was the sale of Eagan-based trucker Transport America to TransForce of Canada for $310 million. That deal also gives some insight into how profitable these deals can be for patient sellers who add value during their ownership.
Transport, once a public company, went private in a 2006 deal valued at about $110 million. It was led by Minneapolis-based private equity investor Goldner Hawn Johnson & Morrison.